| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥6598.8B | ¥7561.1B | -12.7% |
| Operating Income | ¥-537.7B | ¥-437.3B | - |
| Profit Before Tax | ¥-558.8B | ¥-453.7B | - |
| Net Income | ¥-589.1B | ¥526.3B | +320.2% |
| ROE | -15.1% | 12.0% | - |
FY2026 Q3 results show revenue of 659.9B yen (YoY -12.7%), operating loss of 53.8B yen (versus prior year operating loss of 43.7B yen), and net loss of 58.9B yen (versus prior year net income of 52.6B yen). The company recorded a significant impairment loss of 60.8B yen during the quarter, which was the primary driver of earnings deterioration. Gross profit margin declined to 17.6%, while selling, general and administrative expenses remained elevated at 158.7B yen. Despite the net loss, operating cash flow remained positive at 73.2B yen, generating free cash flow of 31.1B yen. Total assets decreased to 989.6B yen from 1,061.3B yen, while equity declined to 391.2B yen, resulting in an equity ratio of 39.1%.
[Profitability] ROE of -15.1% deteriorated significantly from prior period, driven by net profit margin of -8.9%, asset turnover of 0.667, and financial leverage of 2.53x. Operating margin of -8.1% compares unfavorably to the prior year operating margin of 0.6%, with gross profit margin at 17.6% indicating pricing pressure or unfavorable product mix. ROA stands at -6.0% and ROIC at -13.7%, reflecting inefficient capital deployment. [Cash Quality] Cash and equivalents totaled 122.2B yen, increasing 14.6B yen from prior year, providing adequate liquidity coverage. Operating cash flow of 73.2B yen represents -1.24x of net income, with the divergence primarily attributable to non-cash impairment charges. Free cash flow of 31.1B yen covers annual dividends with a coverage ratio of 3.14x. [Investment Efficiency] Asset turnover of 0.667 indicates below-average utilization of assets. Working capital efficiency requires improvement with receivables at 169.8B yen, inventory at 224.1B yen, and payables at 99.4B yen. Days sales outstanding, days inventory outstanding, and operating working capital turnover all indicate extended cash conversion cycles. [Financial Health] Equity ratio of 39.1% decreased from 41.3% in the prior year, reflecting retained earnings decline of 67.6B yen (-29.2%). Total liabilities of 598.4B yen result in a debt-to-equity multiplier of 1.53x. Current assets of 573.2B yen represent 57.9% of total assets, maintaining adequate short-term liquidity position.
Operating cash flow of 73.2B yen remained positive despite the net loss of 58.9B yen, with the divergence primarily reflecting the 60.8B yen non-cash impairment charge and other non-operating expenses. The operating CF to net income ratio of -1.24x highlights earnings quality concerns that require monitoring, though the positive operating cash generation demonstrates underlying operational cash-generating capability. Investing cash flow of -42.1B yen was driven by capital expenditures of 43.9B yen, which continue at moderate levels. Free cash flow of 31.1B yen indicates the company maintained cash generation capacity even during the loss period. Cash and deposits increased 14.6B yen year-over-year to 122.2B yen, supported by positive operating cash flow offsetting investment and financing outflows. Working capital dynamics show elevated receivables of 169.8B yen and inventory of 224.1B yen, indicating opportunities for efficiency improvements through accelerated collections and inventory turnover. The free cash flow coverage of dividends at 3.14x demonstrates that current dividend commitments of 25 yen per share remain supported by cash generation, though the negative net income basis raises sustainability questions absent earnings recovery.
Operating loss of 53.8B yen versus net loss of 58.9B yen indicates non-operating net loss contribution of approximately 5.1B yen. Non-operating items include financial income of 3.2B yen offset by financial costs of 7.7B yen and other expenses of 16.6B yen. The impairment loss of 60.8B yen recorded in the period represents a significant non-recurring charge that distorts underlying operating performance assessment. Excluding this impairment, adjusted operating performance would show improvement, though structural profitability challenges remain with the 17.6% gross margin and elevated SG&A burden of 158.7B yen. Operating cash flow exceeding net income in absolute terms indicates that non-cash charges, particularly the impairment, are the primary driver of the earnings-cash divergence. Financial expenses and other costs totaling approximately 18.9B yen represent ongoing burdens that compress earnings. The composition of non-operating expenses, particularly the 16.6B yen in other expenses, warrants detailed examination to assess recurrence risk. While the large impairment suggests asset writedown or restructuring activity that may be non-recurring, the underlying operating margin deterioration and revenue decline of 12.7% indicate fundamental business performance challenges that require operational improvements beyond one-time charges.
Revenue decline risk remains elevated with Q3 revenues down 12.7% year-over-year to 659.9B yen, raising concerns about demand weakness, competitive pressures, or market share loss. The full-year revenue forecast of 860.0B yen implies Q4 recovery that appears challenging given current trajectory. Profitability structure risk is evidenced by the 17.6% gross margin and operating loss of 53.8B yen, with SG&A expenses of 158.7B yen representing 24.0% of sales. Absent significant cost structure realignment or revenue recovery with improved mix, sustained profitability remains uncertain. Asset impairment recurrence risk is highlighted by the 60.8B yen impairment charge in the current quarter, with equity method investments declining 8.2B yen (-17.9%) and property, plant and equipment decreasing 30.3B yen year-over-year, suggesting potential for additional writedowns if business conditions do not improve or if asset valuations face further pressure.
[Industry Position] (Reference - Proprietary Analysis) Profitability: Net profit margin of -8.9% significantly underperforms the retail industry median of 2.2%, while operating margin of -8.1% trails the industry median of 3.9%. ROE of -15.1% substantially lags the industry median of 2.9%, and ROIC of -13.7% compares poorly to the industry median of 7.0%. Financial Health: Equity ratio of 39.1% falls below the retail industry median of 56.8%, indicating higher leverage relative to peers. Financial leverage of 2.53x exceeds the industry median of 1.76x. Current ratio information is available with the company maintaining adequate liquidity despite elevated leverage. Efficiency: Asset turnover of 0.667 underperforms the industry median of 0.95, reflecting lower asset utilization efficiency. Operating working capital turnover metrics indicate extended cash conversion cycles, with receivables turnover, inventory turnover of 224 days significantly exceeding industry median of 96 days, and payables turnover requiring improvement relative to the industry median of 59 days. Growth: Revenue growth of -12.7% substantially trails the retail industry median of 3.0%, representing significant underperformance in top-line expansion. Industry: Retail sector (16 companies), Comparison: 2025-Q3 period, Source: Proprietary analysis
Revenue contraction of 12.7% combined with operating losses and significant asset impairments indicate fundamental business model challenges requiring comprehensive operational restructuring. The 17.6% gross margin and 24.0% SG&A-to-sales ratio create structural profitability headwinds that necessitate both revenue quality improvement through product mix optimization and aggressive cost rationalization to restore sustainable profitability. Positive operating cash flow of 73.2B yen and free cash flow of 31.1B yen demonstrate that underlying cash generation capability persists despite accounting losses, providing financial flexibility to execute turnaround initiatives while maintaining the 25 yen dividend, though earnings recovery remains essential for long-term dividend sustainability given the -16.8% payout ratio on a net income basis. Working capital metrics revealing elevated inventory of 224.1B yen with 224-day turnover and extended receivables collection indicate operational efficiency opportunities that could unlock significant cash and improve return metrics. The substantial negative divergence from industry benchmarks across profitability, efficiency, and growth dimensions underscores the magnitude of performance gap requiring closure through strategic portfolio review, potential non-core asset divestiture evidenced by the 60.8B yen impairment, and focused investment in higher-margin business segments to drive ROIC recovery toward target levels above 7-8%.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.